Stock listing
Lantern Pharma Inc.
Selected listing: LTRN · NASDAQ · USD · US
Lantern Pharma Inc. (NASDAQ:LTRN), Health Technology. Latest release Oct 8, 2026: Lantern Pharma to Present at the ThinkEquity Conference in NYC on October…
- Ticker
- NASDAQ:LTRN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Lantern Pharma Inc.
Lantern Pharma Inc. is a public company traded under the ticker LTRN in the American market. Lantern Pharma focuses on developing targeted cancer therapies using its proprietary technology to improve treatment outcomes for patients.
Latest news from Lantern Pharma Inc.
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
October 7, 2026
Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
October 6, 2026
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
September 30, 2026
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
September 29, 2026
Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET
September 23, 2026